勘误：细胞焦亡与gasdermin蛋白——代谢功能障碍相关脂肪性肝炎的新见解与治疗机遇
Corrigendum: Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis.
作者信息
Stoess Christian, Leszczynska Aleksandra, Kui Lin, Feldstein Ariel E
机构信息
Department of Pediatric Gastroenterology, University of California, San Diego, San Diego, CA, United States.
Department of Surgery, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
出版信息
Front Cell Dev Biol. 2024 Oct 16;12:1461581. doi: 10.3389/fcell.2024.1461581. eCollection 2024.
Abstract
[This corrects the article DOI: 10.3389/fcell.2023.1218807.].
摘要
[本文更正了文章DOI：10.3389/fcell.2023.1218807。]
相似文献
1
Corrigendum: Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis.勘误：细胞焦亡与gasdermin蛋白——代谢功能障碍相关脂肪性肝炎的新见解与治疗机遇
Front Cell Dev Biol. 2024 Oct 16;12:1461581. doi: 10.3389/fcell.2024.1461581. eCollection 2024.
2
Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis.细胞焦亡与gasdermin蛋白——代谢功能障碍相关脂肪性肝炎的新见解与治疗机会
Front Cell Dev Biol. 2023 Aug 17;11:1218807. doi: 10.3389/fcell.2023.1218807. eCollection 2023.
3
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases.代谢功能障碍相关脂肪性肝病（MASLD）和代谢功能障碍相关脂肪性肝炎（MASH）对心脏、肌肉和肾脏相关疾病的全身影响。
Front Cell Dev Biol. 2024 Jul 16;12:1433857. doi: 10.3389/fcell.2024.1433857. eCollection 2024.
4
Mechanism of PANoptosis in metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病中 PANoptosis 的机制。
Clin Res Hepatol Gastroenterol. 2024 Aug;48(7):102381. doi: 10.1016/j.clinre.2024.102381. Epub 2024 May 29.
5
ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH.ACMSD抑制可纠正代谢相关脂肪性肝病/非酒精性脂肪性肝炎中的纤维化、炎症和DNA损伤。
J Hepatol. 2025 Feb;82(2):174-188. doi: 10.1016/j.jhep.2024.08.009. Epub 2024 Aug 22.
6
Myeloid Trem2 ameliorates the progression of metabolic dysfunction-associated steatotic liver disease by regulating macrophage pyroptosis and inflammation resolution.髓系细胞表面表达的触发受体 2 通过调节巨噬细胞焦亡和炎症消退改善代谢相关脂肪性肝病的进展。
Metabolism. 2024 Jun;155:155911. doi: 10.1016/j.metabol.2024.155911. Epub 2024 Apr 10.
7
Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10.通过抑制肝 N-乙酰基转移酶 10 改善 MASLD 和 MASH。
Mol Metab. 2024 Nov;89:102030. doi: 10.1016/j.molmet.2024.102030. Epub 2024 Sep 16.
8
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease.低至中度饮酒与代谢功能障碍相关脂肪性肝病患者的纤维化增加有关。
J Hepatol. 2024 Dec;81(6):930-940. doi: 10.1016/j.jhep.2024.06.036. Epub 2024 Jul 4.
9
Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.基于性别的差异，自然杀伤 T 细胞在保护 Balb/c 小鼠抵抗饮食诱导的脂肪性肝炎中的作用。
Biol Sex Differ. 2023 Nov 14;14(1):85. doi: 10.1186/s13293-023-00569-w.
10
Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study.经活检证实的脂肪性肝病和脂肪性肝炎患者的循环激素：一项多中心观察性研究。
Metabolism. 2023 Nov;148:155694. doi: 10.1016/j.metabol.2023.155694. Epub 2023 Sep 25.
Zotero 插件